MetaCap

TransMedics Group Statistics

NASDAQ: TMDXHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

85.25-8.77 (-9.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TransMedics Group by the numbers

TransMedics Group has a market capitalization of $2.96 billion based on 34.73M shares outstanding. Its trailing P/E ratio is 23.2, above the 4-company peer median of 18.0, and its forward P/E is 34.3. The stock trades 5.4% above its 50-day average and 5.9% below its 200-day average.

Average daily trading volume is 930.13K shares, or about $79.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

TMDX valuation vs. peer median

TMDX compared with the median of 8 peer companies
MetricTMDXPeer medianDifference
Market cap$2.96B$889.19M+233%
P/E (TTM)23.218.0+29%
Forward P/E34.319.2+79%
Avg. volume930.13K408.47K+128%

Peer median across 8 companies: AXGN, CNMD, CBLL, LIVN, INMD, CV, ELMD, FOCL.

Valuation

Price / sales (latest FY)
4.89

Price and trading

Previous close
94.02
Open
91.62
Day range
83.89 – 91.62
52-week range
60.11 – 156.00
52-week change
-34.89%
Beta
—
Volume
1.59M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.96B
Pe
23.23
Forward Pe
34.31
Eps
3.67
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
156.00
Week52 Low
60.11
Avg Volume
930.13K
Shares Outstanding
34.73M
Ma50
80.88
Ma200
90.62
Earnings Date
Nov 5, 2026
Pct From52w High
-45.35%
Pct From52w Low
41.84%

Related